Clinical Social Workers in Eunice, LA Accepting Medicare

6 Clinical Social Workers found. Showing 1 - 6

Donna Wilson Wimberly, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 230 West Walnut Avenue, Eunice, LA 70535 Phone: 337-457-3338

Mrs. Andrea Jeanne Vidrine, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 130 S 3rd St, Eunice, LA 70535 Phone: 337-457-3000    Fax: 337-457-3055

Kara Elizabeth Clark, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5106 Henry Bieber Rd, Eunice, LA 70535 Phone: 325-203-7838

Samuel Joseph Fusilier, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 128 Adeline Dr, Eunice, LA 70535 Phone: 337-457-8456    Fax: 337-363-1567

Mr. Joseph Claude Devillier, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 497 Willie Young Rd, Eunice, LA 70535 Phone: 337-580-3870

Mrs. Jennifer A. Glasscock, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3320 Highway 190, Eunice, LA 70535 Phone: 133-466-3530

News Archive

Wayne State researchers win NIH grant to uncover new antibiotic targets

A research team from Wayne State University has received a $1.85 million grant from the National Institute of General Medical Sciences of the National Institutes of Health for the project "Mechanisms of Non-Shine-Dalgarno Translation Initiation."

OncoSec Medical closes sale of 31,000,000 shares of common stock in registered public offering

OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, announced today the closing of the sale to institutional investors of an aggregate of 31,000,000 shares of its common stock at $0.25 per share in a registered public offering.

Health law mostly untouched by agreement to end shutdown, increase debt limit

Republican foes of the overhaul came out of the confrontation with only a tweak to income verification rules for those seeking subsidies to buy coverage on the new health insurance exchanges. The agreement created a new budget deadline, however, requiring lawmakers to return to the table to reach a long-term deficit reduction agreement by Dec. 1

Tyrogenex announces results from phase 1 study of orally-administered X-82 in patients with AMD

Tyrogenex, a privately held company focused on the development of targeted therapeutics for cancer and ophthalmology, today announced data from its phase 1 open-label study of orally-administered X-82 in patients for wet age-related macular degeneration (AMD).

Read more Medical News

› Verified 5 days ago